Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.66% |
| 2 | Healthcare | 6.72% |
| 3 | Technology | 5.11% |
| 4 | Financials | 3.78% |
| 5 | Energy | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $9.5B | 10.72% |
46,569,190
+15,521,860
| +50% | +$3.26B |
2013 Q2
8 quarters
|
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $7.21B | 8.1% |
35,191,537
+13,911,996
| +65% | +$2.93B |
2013 Q2
8 quarters
|
|
|
3
PUT
iShares Russell 2000 ETF
IWM
$77.1B
| $3.23B | 3.62% |
26,026,300
+5,339,100
| +26% | +$667M |
2013 Q2
8 quarters
|
|
|
4
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $2.42B | 2.72% |
11,828,140
+2,299,700
| +24% | +$484M |
2013 Q2
8 quarters
|
|
|
5
PUT
Bausch Health
BHC
$3.13B
| $1B | 1.12% |
4,510,900
-2,082,800
| -32% | -$462M |
2013 Q2
8 quarters
|
|
|
6
Bausch Health
BHC
$3.13B
| $859M | 0.96% |
3,868,637
-2,182,040
| -36% | -$484M |
2013 Q2
8 quarters
|
|
|
7
CALL
iShares Russell 2000 ETF
IWM
$77.1B
| $832M | 0.93% |
6,713,600
-882,800
| -12% | -$110M |
2013 Q2
8 quarters
|
|
|
8
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $802M | 0.9% |
20,558,100
+13,174,100
| +178% | +$551M |
2013 Q2
8 quarters
|
|
|
9
iShares Russell 2000 ETF
IWM
$77.1B
| $736M | 0.83% |
5,939,108
+1,750,129
| +42% | +$219M |
2013 Q2
8 quarters
|
|
10
Apple
AAPL
$5.18T
| $691M | 0.78% |
22,099,652
+475,804
| +2% | +$15.2M |
2013 Q2
8 quarters
|
|
|
11
CALL
Apple
AAPL
$5.18T
| $667M | 0.75% |
21,339,480
-2,973,760
| -12% | -$95.1M |
2013 Q2
8 quarters
|
|
|
12
Johnson & Johnson
JNJ
$689B
| $658M | 0.74% |
6,779,300
+2,094,332
| +45% | +$210M |
2013 Q2
8 quarters
|
|
|
13
PUT
Apple
AAPL
$5.18T
| $645M | 0.72% |
20,641,000
+7,514,840
| +57% | +$240M |
2013 Q2
8 quarters
|
|
14
PUT
Bank of America
BAC
$352B
| $473M | 0.53% |
27,850,700
+21,665,900
| +350% | +$357M |
2013 Q2
8 quarters
|
|
|
15
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $451M | 0.51% |
11,568,400
-4,088,900
| -26% | -$171M |
2013 Q2
8 quarters
|
|
16
IBM
IBM
$234B
| $444M | 0.5% |
2,867,798
+1,229,922
| +75% | +$198M |
2013 Q2
8 quarters
|
|
17
Microsoft
MSFT
$3.89T
| $416M | 0.47% |
9,450,372
-1,802,105
| -16% | -$82.2M |
2013 Q2
8 quarters
|
|
18
Pfizer
PFE
$165B
| $415M | 0.47% |
13,240,025
+1,389,403
| +12% | +$45.3M |
2013 Q2
8 quarters
|
|
19
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $413M | 0.46% |
4,692,700
+3,347,900
| +249% | +$303M |
2013 Q2
8 quarters
|
|
|
20
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $409M | 0.46% |
10,490,087
+7,092,078
| +209% | +$297M |
2013 Q2
8 quarters
|
|
21
ExxonMobil
XOM
$696B
| $403M | 0.45% |
4,849,841
+842,775
| +21% | +$72.5M |
2013 Q2
8 quarters
|
|
22
PUT
iShares China Large-Cap ETF
FXI
$3.84B
| $401M | 0.45% |
8,715,800
-1,550,500
| -15% | -$76.8M |
2013 Q2
8 quarters
|
|
23
PUT
Gilead Sciences
GILD
$208B
| $387M | 0.43% |
3,305,700
-1,246,100
| -27% | -$136M |
2013 Q2
8 quarters
|
|
|
24
Bank of America
BAC
$352B
| $382M | 0.43% |
22,498,762
+5,710,543
| +34% | +$94.1M |
2013 Q2
8 quarters
|
|
|
25
AT&T
T
$149B
| $369M | 0.41% |
13,975,584
-10,807,168
| -44% | -$279M |
2013 Q2
8 quarters
|
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays withdrew a net $2.85B in Q2 2015, closing 450 positions and reducing 3,770 holdings. Its most notable exit was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 60% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Barclays opened a new position in Element Solutions worth $20M.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.